Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.41 USD
Change Today +0.01 / 0.71%
Volume 17.5K
ATEC On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

alphatec holdings inc (ATEC) Snapshot

Open
$1.40
Previous Close
$1.40
Day High
$1.43
Day Low
$1.40
52 Week High
09/17/14 - $1.92
52 Week Low
05/9/14 - $1.20
Market Cap
140.8M
Average Volume 10 Days
51.5K
EPS TTM
$-0.12
Shares Outstanding
99.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ALPHATEC HOLDINGS INC (ATEC)

Related News

No related news articles were found.

alphatec holdings inc (ATEC) Related Businessweek News

No Related Businessweek News Found

alphatec holdings inc (ATEC) Details

Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, manufacturing, and marketing of products for the surgical treatment of spine disorders worldwide. Its product portfolio and pipeline addresses the cervical, thoracolumbar, and intervertebral regions of the spine, as well as covers various spinal disorders and surgical procedures. The company offers cervical and cervico-thoracic products, including Trestle Anterior Cervical Plate, Trestle Luxe Anterior Cervical Plate, Solanas Posterior Cervico/Thoracic Fixation system, and Avalon Occipital Plate. It also provides thoracolumbar fixation products, such as Arsenal Degenerative System, Zodiac Degenerative Spinal Fixation System, Zodiac Deformity Spinal Fixation System, Aspida Anterior Lumbar Interbody Fusion, and OsseoScrew Spinal Fixation System, as well as ILLICO FS Fixation System, Xenon Degenerative Fixation System, Hemi Fixation System, and OsseoFix+ Vertebroplasty System. In addition, the company offers Spinal Spacers comprising Novel PEEK and Titanium Spinal Spacers, Alphatec Solus Locking ALIF Spacer, Samarys, and Pegasus Anchored Cervical Interbody; Minimally Invasive Surgery (MIS) products, including Illico MIS System and BridgePoint Spinous Process Fixation System; and Biologics, such as AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffolds, Amnioshield Amniotic Tissue Barrier, AlphaGraft Demineralized Bone Matrix, and NEXoss Synthetic Bone Graft, as well as AmnioShield Amniotic Membrane and Autologous Bone Harvester. Further, it provides DiscoCerv Artificial Disc, PCB Evolution, TTL IN Fixation System, Isobar Evolution Dynamic Rod, TTL-D Fixation System, OsseoFix Spinal Fracture Reduction System, OsseoScrew Spinal Fixation System, Samarys/Samarys RF, HeliFix Interspinous Spacer System, TeCorp, OsseoScrew MIS System, and Epicage TLIF System. The company was founded in 1990 and is headquartered in Carlsbad, California.

450 Employees
Last Reported Date: 02/27/15
Founded in 1990

alphatec holdings inc (ATEC) Top Compensated Officers

Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $325.0K
President of Alphatec Pacific Inc
Total Annual Compensation: $354.6K
Compensation as of Fiscal Year 2013.

alphatec holdings inc (ATEC) Key Developments

Alphatec Holdings, Inc. Announces Executive Changes, Effective from May 1, 2014

Effective May 1, 2014, the Board of Directors of Alphatec Holdings, Inc. appointed James M. Corbett as the President and Chief Executive Officer of the company. Mr. Corbett succeeds Leslie H. Cross, who has decided to retire and is resigning from his position as Chief Executive Officer, effective May 1, 2014. Mr. Cross will remain Chairman of the Board. On April 25, 2014, Mr. Corbett was also appointed to the Board, effective May 1, 2014 to fill the vacancy created by the resignation of Luke T. Faulstick from the Board, effective May 1, 2014. In addition, effective May 1, 2014 the company has decided to eliminate the position of Senior Vice President, U.S. Commercial Operations, which is held by Thomas McLeer and whose employment with the company will end. Mr. McLeer will receive severance compensation in accordance with the terms of his employment agreement. Prior to joining the Company, Mr. Corbett, served as the President and Chief Executive Officer of Vertos Medical, Inc.

Alphatec Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Earnings Guidance for the Year 2015

Alphatec Holdings, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported revenues of $53,627,000 compared to $53,065,000 a year ago. Operating income was $2,973,000 compared to operating loss of $56,002,000 a year ago. Loss from continuing operations before taxes was $134,000 compared to $58,111,000 a year ago. Net loss was $273,000 or $0.03 per diluted share compared to $60,407,000 or $0.62 per diluted share a year ago. EBITDA, as adjusted for significant items was $8,265,000 compared to $7,496,000 a year ago. Net loss, as adjusted for significant items was $1,677,000 or $0.02 per basic and diluted share compared to $1,941,000 or $0.02 per basic and diluted share a year ago. For the year, the company reported revenues of $206,980,000 compared to $204,724,000 a year ago. Operating income was $1,844,000 compared to operating loss of $73,433,000 a year ago. Loss from continuing operations before taxes was $11,795,000 compared to $79,048,000 a year ago. Net loss was $12,882,000 or $0.16 per diluted share compared to $82,227,000 or $0.85 per diluted share a year ago. EBITDA, as adjusted for significant items was $30,831,000 compared to $25,182,000 a year ago. Net loss, as adjusted for significant items was $3,187,000 or $0.13 per basic and diluted share compared to $2,328,000 or $0.85 per basic and diluted share a year ago. The company anticipates full year 2015 constant currency revenue growth of approximately 4% to 7% over 2014, which represents a range of revenue in constant currency of $215 million to $222 million. Additionally, the company expects annual adjusted EBITDA of $34 million to $37 million in 2015, representing a range of approximately 10% to 20% growth over 2014.

Alphatec Holdings, Inc. to Report Q4, 2014 Results on Feb 26, 2015

Alphatec Holdings, Inc. announced that they will report Q4, 2014 results at 5:00 PM, US Eastern Standard Time on Feb 26, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATEC:US $1.41 USD +0.01

ATEC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Exactech Inc $24.40 USD +0.15
K2M Group Holdings Inc $22.87 USD -0.71
Landauer Inc $34.60 USD -0.17
Misonix Inc $13.28 USD -0.08
RTI Surgical Inc $5.86 USD +0.09
View Industry Companies
 

Industry Analysis

ATEC

Industry Average

Valuation ATEC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.7x
Price/Book 0.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALPHATEC HOLDINGS INC, please visit www.alphatecspine.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.